Healthcare Global Bivalirudin and Desmopressin Market | Page 2

“Bivalirudin and Desmopressin Market: Global Demand
Analysis & Opportunity Outlook 2024”
The global bivalirudin and desmopressin market is segmented into use such
as Percutaneous Transluminal Coronary Angioplasty (PTCA) procedures,
Percutaneous Coronary Intervention (PCI) procedures and others. Among
these segments, Percutaneous Transluminal Coronary Angioplasty (PTCA)
procedures segment is expected to occupy top position in overall
bivalirudin and desmopressin market during the forecast period. Rising
demand for minimally invasive procedure to open up blocked coronary
arteries is fuelling the growth of Percutaneous Transluminal Coronary
Angioplasty (PTCA) procedures segment.
Global Bivalirudin and Desmopressin Market is expected to flourish
at a significant CAGR during the forecast period. Increasing incidences of
cardiovascular diseases is spurring the growth of the global bivalirudin and
desmopressin market. Moreover, the global bivalirudin and desmopressin
market is expected to garner noteworthy revenue by the end of 2024.
North America captured largest market for bivalirudin and desmopressin in
2015. Further, North America is projected to continue its dominance over
the forecast period. High number of adults suffering with heart disease is
driving the growth of the bivalirudin and desmopressinin market. Europe is
anticipated to substantially contribute to the growth of bivalirudin and
desmopressin market. This can be attributed to the growing absolute
number of CVD (cardiovascular) cases in the region. Moreover, increase in
number of new CVD cases is anticipated to grow the demand for bivalirudin
and desmopressinin in the region. Asia Pacific is anticipated to showcase
lucrative growth in bivalirudin and desmopressin market during the
forecast period.
Request Report Sample @ https://www.researchnester.com/sample-
request/2/rep-id-266
Copyright © Research Nester
www.researchnester.com